1. Yan, Huaying, Guo, Wenhao, Li, Ke, Nie, Chun-Lai, Yuan, Zhu. 2018. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis. In Experimental cell research, 371, 50-62. doi:10.1016/j.yexcr.2018.07.040. https://pubmed.ncbi.nlm.nih.gov/30055135/
2. Lin, Chao, Yan, HuaYing, Yang, Jun, Wei, Yuquan, Yuan, Zhu. 2017. Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma. In Oncotarget, 8, 56281-56295. doi:10.18632/oncotarget.17623. https://pubmed.ncbi.nlm.nih.gov/28915590/
3. Shen, Cong-Cong, Cui, Xin-Yi, He, Yi, Yang, Jin-Liang, Gou, Lan-Tu. 2014. High Phosphorylation Status of AKT/mTOR Signal in DESI2-Reduced Pancreatic Ductal Adenocarcinoma. In Pathology oncology research : POR, 21, 267-72. doi:10.1007/s12253-014-9817-3. https://pubmed.ncbi.nlm.nih.gov/25079376/
4. Jiang, Rui, He, Qin, Song, Jingyi, Xie, Conghua, Du, Juan. 2023. A Phytophthora infestans RXLR effector AVR8 suppresses plant immunity by targeting a desumoylating isopeptidase DeSI2. In The Plant journal : for cell and molecular biology, 115, 398-413. doi:10.1111/tpj.16232. https://pubmed.ncbi.nlm.nih.gov/37021636/
5. Bijkerk, Roel, Esguerra, Jonathan L S, Ellenbroek, Johanne H, Eliasson, Lena, van Zonneveld, Anton Jan. 2019. In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion. In Nucleic acid therapeutics, 29, 67-72. doi:10.1089/nat.2018.0763. https://pubmed.ncbi.nlm.nih.gov/30672723/
6. Shinden, Yoshiaki, Hirashima, Tadahiro, Nohata, Nijiro, Kijima, Yuko, Seki, Naohiko. 2020. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes. In Journal of human genetics, 66, 519-534. doi:10.1038/s10038-020-00865-y. https://pubmed.ncbi.nlm.nih.gov/33177704/
智鼠故事 
